Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.
about
PTEN deficiency mediates a reciprocal response to IGFI and mTOR inhibition.Bone- and cartilage-forming tumors and ewing sarcoma: an update with a gnathic emphasis.Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology GroupVariable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology GroupExtraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal ManagementTherapy resistance mechanisms in Ewing's sarcoma family tumors.Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma.Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.Prognostic significance of serum lactate dehydrogenase levels in Ewing's sarcoma: A meta-analysis.Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma.A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcomaSink or Collaborate: How the Immersive Model Has Helped Address Typical Adolescent and Young Adult Barriers at a Single Institution and Kept the Adolescent and Young Adult Program Afloat.Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor.Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors.
P2860
Q34518277-39DD9BD7-11A0-45CD-B6E1-6670FAE63A24Q34577384-1C29B5BC-962D-4CB5-B186-BAB92D5B16BAQ35224434-8398ACF0-87E8-48CF-A511-F2A8B75D45D2Q35545322-E88EBEDA-C13F-4771-BBB9-B690128FE58EQ35688154-8D2FFCE9-8F3F-439D-A00C-3F1BD65B456DQ36844984-347B5DC4-4238-4140-AA81-981BC5303DF9Q38182423-21C7DBE9-2DC0-49DB-B54B-26DFA8A0E2C6Q38749818-797EA3C4-12E5-4D7C-BD0D-D071AD1DB1FAQ39013447-0D30738E-A844-4339-9363-818823D77F78Q39095969-A37DFCE1-DF7B-4A13-865F-1E88700A2EE9Q39100241-3C0D7CB1-94EE-4462-B723-61515BCB2D3AQ42321604-8E4F07F5-661E-4B05-AC18-D7576D929433Q44707233-CCF8A45B-5DA1-488D-83B5-75182E290ED3Q47733296-B2DF6DB2-8083-48D1-B65D-9101722D64EFQ52148322-742742AF-E04B-4840-98EB-DCF6B9014A21
P2860
Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Biomarkers in Ewing Sarcoma: T ...... the Children's Oncology Group.
@en
type
label
Biomarkers in Ewing Sarcoma: T ...... the Children's Oncology Group.
@en
prefLabel
Biomarkers in Ewing Sarcoma: T ...... the Children's Oncology Group.
@en
P2093
P2860
P356
P1476
Biomarkers in Ewing Sarcoma: T ...... the Children's Oncology Group
@en
P2093
COG Ewing Sarcoma Biology Committee
Elizabeth R Lawlor
Ian J Davis
Joshua Schiffman
Neerav Shukla
Richard B Womer
Stephen L Lessnick
P2860
P356
10.3389/FONC.2013.00141
P577
2013-06-06T00:00:00Z